Status:

COMPLETED

Dry Needling and Spinal Manipulation vs. Interocclusal Appliance (Splint), NSAIDs and Joint Mobs for Temporomandibular Dysfunction

Lead Sponsor:

Alabama Physical Therapy & Acupuncture

Collaborating Sponsors:

Universidad Rey Juan Carlos

Conditions:

Temporomandibular Joint Dysfunction Syndrome

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this research is to compare two different approaches for treating patients with temporomandibular dysfunction (TMD): Dry needling and spinal manipulation or Interocclusal Appliance (Spl...

Detailed Description

Patients with stress temporomandibular dysfunction will be randomized to receive 1-2 treatment sessions per week for up to 4 weeks ( up to 8 sessions total) of either: (1) dry needling and spinal mani...

Eligibility Criteria

Inclusion

  • Patients at least 18 years old
  • Patient referred to physical therapy from a physician or dentist with a diagnosis of temporomandibular dysfunction that is consistent with the Revised TMD Group 1 Muscle Disorders Diagnostic Algorithm. (Dworkin et al.1992; Look et al., 2010\]. According to Blanco-Hungria et al. (2015), this category represents 88.7% of patients with TMD.
  • History of symptoms related to TMD for at least 3 months
  • Intensity of pain related to TMD at least 30mm out 100 per Visual Analogue scale (La Touche et al, 2009; Gonzalez-Ingesias et al., 2013)
  • Patient presents with the following: (Gonzalez Perez et al., 2015)
  • Strong pain in the anterior part of the lower belly of the LPM on palpation
  • Deep-seated pain in the TMJ and/or region of the maxillary sinus (referred pain)
  • Significant motor dysfunction (e.g. limited jaw opening, painful protrusion of the chin against resistance, mandibular lateralization to the opposite side upon opening).

Exclusion

  • Report of red flags to manual physical therapy to include: severe hypertension, infection, ankylosing spondylitis, neoplasm, uncontrolled diabetes, peripheral neuropathy, heart disease, stroke, chronic, ischemia, edema, severe varicosities, tumor, metabolic disease, prolonged steroid use, fracture, RA, osteoporosis, severe vascular disease, malignancy, etc.
  • Signs or symptoms of disc displacement, arthrosis or arthritis of the temporomandibular joint according to category II and III of the Research Diagnostic Criteria for Temporomandibular Disorders
  • History of traumatic injury such as a fracture or whiplash
  • Concomitant diagnosis of any primary headache (i.e. tension type headache or Migraine) except cervicogenic headaches
  • History of surgery related to TMD
  • Diagnosis of fibromyalgia
  • Systemic disease such as RA, lupus erythematosus or psoriatic arthritis
  • Presence of neurological disorder such as trigeminal neuralgia
  • History of PT, acupuncture or splint treatment within 3 months of the study
  • History of taking prescription NSAIDs within 3 months of the study
  • History of regularly taking non-prescription NSAIDs (i.e. more than intermittent) within 3 months of the study
  • Known sensitivity to acetylsalicylic acid, with impaired coagulation or with ulcer, kidney or liver problems.
  • Cadiac pacemaker, metal allergy or severe needle phobia
  • Serious cardiovascular, cerebral disease, psychiatric disorder or cognitive Impairment
  • Pregnancy

Key Trial Info

Start Date :

February 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2020

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT03409874

Start Date

February 1 2018

End Date

July 1 2020

Last Update

December 29 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Physiomed-lab

Thessaloniki, Greece